FUNC
First United Corporation
FUNC's outlook is improving, though it still trails on the overall score.
JPM
JPMorgan Chase & Co.
JPM has the edge over FUNC overall, supported by stronger fundamentals and stronger modeled upside.
FUNC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
FUNC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FUNC.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FUNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.3x | $20.60 | -56% |
| Fair | 8.6x | $33.56 | -28% |
| Forward | 9.6x | $46.40 | — |
| Expensive | 11x | $44.55 | -4% |
| Current | 12x | $46.40 | — |
Historical ranges are pointers, not guarantees.
FUNC's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 9.6x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over FUNC in the historical PE scenario, which offers more potential upside but is not a forecast.
FUNC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
FUNC has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FUNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.83 | +23% |
| Q3 2026 | $3.91 | +2.1% |
| Q2 2026 | $3.87 | +6% |
| Q1 2026 | $3.91 | +12% |
| Q4 2025 | $3.77 | +20% |
| Q3 2025 | $3.83 | +55% |
| Q2 2025 | $3.65 | +62% |
| Q1 2025 | $3.48 | +61% |
| Q4 2024 | $3.15 | +40% |
FUNC has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
FUNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.2M | +11% |
| Q2 2026 | $23.9M | +9.9% |
| Q1 2026 | $23.4M | +12% |
| Q4 2025 | $23.2M | +12% |
| Q3 2025 | $22.7M | +12% |
| Q2 2025 | $21.8M | +8.5% |
| Q1 2025 | $20.9M | +12% |
| Q4 2024 | $20.8M | +40% |
FUNC has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -3.1 points |
| Q2 2026 | 31% | -5.6 points |
| Q1 2026 | 38% | +1 points |
| Q4 2025 | 33% | -6.4 points |
| Q3 2025 | 41% | +2.7 points |
| Q2 2025 | 37% | +4 points |
| Q1 2025 | 37% | +11 points |
| Q4 2024 | 39% | +25 points |
FUNC's operating margin was 38% last quarter, down 3.1 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over FUNC on profitability, with a higher operating margin.
FUNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.6M | +2621% |
| Q2 2026 | $4.7M | +560% |
| Q1 2026 | $13M | +104% |
| Q4 2025 | $8.2M | -11% |
| Q3 2025 | $168K | -71% |
| Q2 2025 | $706K | -90% |
| Q1 2025 | $6.4M | +81% |
| Q4 2024 | $9.2M | +61% |
FUNC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
FUNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +3K shares |
| 1 year | -0.7% | -44K shares |
| 3 years | -3.9% | -264K shares |
| 5 years | -2.4% | -160K shares |
| Available history | -9% | -637K shares |
FUNC has 6M diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $371,000 |
| Q1 2026 | $2.2M |
| Q4 2024 | $1,000 |
| Q3 2024 | $1,000 |
| Q4 2023 | $1.5M |
| Q4 2021 | — |
| Q3 2021 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FUNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FUNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 3.5x | Elevated |
FUNC has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FUNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 75.8 | Neutral |
FUNC's weekly RSI is 65 (neutral) and its Stochastic is 76 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FUNC PE vs Financial Services Sector
| Metric | FUNC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 8.8% below |
| PE % | 87 | 63 | 24 pts above |
FUNC has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
FUNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.8 | 3.6% above |
| 20 week MA | $44.5 | 4.2% above |
| 50 week MA | $40.8 | 14% above |
| 100 week MA | $37.1 | 25% above |
| 200 week MA | $29.3 | 59% above |
FUNC has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
FUNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.0 | $16.0 | -33% |
| 2021 | $16.0 | $18.7 | +17% |
| 2022 | $18.7 | $19.2 | +2.9% |
| 2023 | $19.2 | $23.5 | +22% |
| 2024 | $23.5 | $33.9 | +44% |
| 2025 | $33.9 | $38.7 | +14% |
| 2026 YTD | $38.7 | $46.4 | +20% |
FUNC has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.